Does TIKOSYN Cause Electrocardiogram qt prolonged? 8 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Electrocardiogram qt prolonged have been filed in association with TIKOSYN. This represents 2.8% of all adverse event reports for TIKOSYN.
8
Reports of Electrocardiogram qt prolonged with TIKOSYN
2.8%
of all TIKOSYN reports
0
Deaths
2
Hospitalizations
How Dangerous Is Electrocardiogram qt prolonged From TIKOSYN?
Of the 8 reports, 2 (25.0%) required hospitalization, and 1 (12.5%) were considered life-threatening.
Is Electrocardiogram qt prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TIKOSYN. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does TIKOSYN Cause?
Drug ineffective (29)
Atrial fibrillation (23)
Cardiac disorder (18)
Malaise (17)
Drug interaction (15)
Fatigue (11)
Headache (11)
Death (10)
Diarrhoea (10)
Dyspnoea (9)
What Other Drugs Cause Electrocardiogram qt prolonged?
QUETIAPINE (1,869)
OLANZAPINE (1,325)
RIBOCICLIB (1,020)
AMIODARONE (1,000)
HYDROXYCHLOROQUINE (992)
CLOZAPINE (958)
CITALOPRAM HYDROBROMIDE (917)
ESCITALOPRAM OXALATE (899)
ONDANSETRON (881)
BUPROPION (853)
Which TIKOSYN Alternatives Have Lower Electrocardiogram qt prolonged Risk?
TIKOSYN vs TILDRAKIZUMAB
TIKOSYN vs TILDRAKIZUMAB-ASMN
TIKOSYN vs TILIDINE
TIKOSYN vs TIMOLOL
TIKOSYN vs TIMOLOL\TRAVOPROST